Table 5.
Number of coronary heart disease events and rates/1000 person years according to randomly allocated treatment and adjusted relative risks (95% confidence intervals) by age at entry
| Age
|
Active
|
Placebo
|
RR (95% CI)
|
|||
|---|---|---|---|---|---|---|
| Events
|
Rate
|
Events
|
Rate
|
|||
| Non-fatal* | ||||||
| <65 | 4 | 4.0 | 18 | 17.6 | 0.13 (0.03 to 0.56) | |
| 65-74 | 14 | 10.5 | 20 | 15.1 | 0.73 (0.36 to 1.47) | |
| ⩾75 | 8 | 11.6 | 8 | 11.0 | 1.40 (0.47 to 4.21) | |
| Fatal† | ||||||
| <65 | 13 | 13.0 | 20 | 19.5 | 0.57 (0.27 to 1.21) | |
| 65-74 | 24 | 17.9 | 24 | 18.1 | 0.98 (0.54 to 1.78) | |
| ⩾75 | 27 | 39.1 | 21 | 28.8 | 1.49 (0.82 to 2.72) | |
| All‡ | ||||||
| <65 | 17 | 17.0 | 38 | 37.1 | 0.38 (0.20 to 0.72) | |
| 65-74 | 38 | 28.4 | 44 | 33.2 | 0.87 (0.55 to 1.37) | |
| ⩾75 | 35 | 50.7 | 29 | 39.8 | 1.47 (0.87 to 2.48) | |
Test for age (continuous variable) and treatment interaction: *P=0.02, †P=0.11, ‡P=0.01.